Factors other than the Duke criteria associated with infective endocarditis among injection drug users

被引:0
|
作者
Palepu, A
Cheung, SS
Montessori, V
Woods, R
Thompson, CR
机构
[1] Univ British Columbia, St Pauls Hosp, Div Gen Internal Med, Vancouver, BC V6Z 1Y6, Canada
[2] Univ British Columbia, St Pauls Hosp, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC V6Z 1Y6, Canada
[3] Univ British Columbia, St Pauls Hosp, Div Infect Dis, Vancouver, BC V6Z 1Y6, Canada
[4] Univ British Columbia, St Pauls Hosp, Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada
[5] Univ British Columbia, St Pauls Hosp, Canadian HIV Clin Trials Network, Vancouver, BC V6Z 1Y6, Canada
[6] Univ British Columbia, St Pauls Hosp, Div Cardiol, Vancouver, BC V6Z 1Y6, Canada
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Modified Duke criteria were applied to consecutive injection drug users (IDUs) who were admitted to an inner-city hospital with a clinical suspicion of infective endocarditis, and the presence of any other clinical variables that were predictive of the presence of infective endocarditis was determined. Methods: Clinical data on consecutive IDUs who were hospitalized over 15 months in Vancouver were collected. Data included the admission history, and findings on physical examination and on initial laboratory investigations. Each subject's course in hospital was followed until discharge or death during the index hospitalization. Follow-up data collected included culture results, the interpretation of the echocardiogram and the discharge diagnosis. The modified Duke criteria were used for the diagnosis of infective endocarditis (definite, possible or rejected). Multiple logistic regression was used to determine what clinical variables (exclusive of the Duke criteria) available within 48 hours of presentation were independent predictors of infective endocarditis. Results: One hundred IDUs were enrolled. Fifty-one were female, and 58 were HIV-positive. Twenty-three met the modified Duke criteria for definite infective endocarditis, and 25 had possible infective endocarditis. IDUs with definite infective endocarditis were more commonly noted to have evidence of vascular phenomena (arterial embolism, septic pulmonary infarction, mycotic aneurysm, intracranial hemorrhage or Janeway lesions) (6 [26%]) than those who had possible endocarditis (1 [4%]). Those with definite infective endocarditis more often had multiple opacities on chest radiography (56% v. < 12%), and fewer had an obvious source of infection (52% v. 72% and 81% of possible and rejected infective endocarditis, respectively). Among febrile IDUs, definite endocarditis was highly associated with having no obvious source of infection (odds ratio 3.1 [95% confidence interval 1.1-8.7]) compared with febrile IDUs with an obvious source of infection. In similarly compared groups, the presence of hematuria, proteinuria or pyuria was also predictive of definite endocarditis (odds ratio 2.9 [95% CI 1.1-8.6]). Conclusions: Among IDUs, the modified Duke criteria are useful for classifying cases with definite infective endocarditis and rejecting cases without infective endocarditis. The classification of possible infective endocarditis is suitable for this population.
引用
下载
收藏
页码:118 / 125
页数:8
相关论文
共 50 条
  • [31] Admissions for Infective Endocarditis in Intravenous Drug Users
    Deo, Salil V.
    Raza, Sajjad
    Kalra, Ankur
    Deo, Vaishali S.
    Altarabsheh, Salah E.
    Zia, Aisha
    Khan, Muhammad Shahzeb
    Markowitz, Alan H.
    Sabik, Joseph F., III
    Park, Soon J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (14) : 1596 - 1597
  • [32] Epidemiology of infective endocarditis in intravenous drug users
    Crociani, Paolo
    Schivazappa, Luciano
    GIORNALE ITALIANO DI CARDIOLOGIA, 2022, 23 (11) : 845 - 853
  • [33] Evaluation of the 2023 Duke-ISCVID criteria for infective endocarditis in patients referred to the Lund infective endocarditis team
    Avogadri, Nils
    Ivarsson, Alex
    Kristensen, Charlotte Burup
    Ragnarsson, Sigurdur
    Rasmussen, Magnus
    INFECTIOUS DISEASES, 2024,
  • [34] Diagnosis of infective endocarditis - Sensitivity of the Duke vs von Reyn criteria
    Heiro, M
    Nikoskelainen, J
    Hartiala, JJ
    Saraste, MK
    Kotilainen, PM
    ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (01) : 18 - 24
  • [35] Human immunodeficiency virus infection and infective endocarditis among injecting drug users
    Manoff, SB
    Vlahov, D
    Herskowitz, A
    Solomon, L
    Munoz, A
    Cohn, S
    Willoughby, SB
    Nelson, KE
    EPIDEMIOLOGY, 1996, 7 (06) : 566 - 570
  • [36] Duke Infective Endocarditis Criteria 3.0 for the Clinician: Defining What Is Possible
    Chambers, Henry F.
    Zhang, ShanShan
    Evans, Scott
    CLINICAL INFECTIOUS DISEASES, 2024, 78 (04) : 964 - 967
  • [37] Factors associated with drug treatment dropout among injection drug users in Puerto Rico
    Marrero, CA
    Robles, RR
    Colón, HM
    Reyes, JC
    Matos, TD
    Sahai, H
    Calderón, JM
    Shepard, EW
    ADDICTIVE BEHAVIORS, 2005, 30 (02) : 397 - 402
  • [38] EVALUATION OF THE DUKE CRITERIA VERSUS THE BETH-ISRAEL CRITERIA FOR THE DIAGNOSIS OF INFECTIVE ENDOCARDITIS
    HOEN, B
    SELTONSUTY, C
    DANCHIN, N
    WEBER, M
    VILLEMOT, JP
    MATHIEU, P
    FLOQUET, J
    CANTON, P
    CLINICAL INFECTIOUS DISEASES, 1995, 21 (04) : 905 - 909
  • [39] Comparable sensitivity of the Duke criteria and the modified Beth Israel criteria for diagnosing infective endocarditis
    MartosPerez, F
    Reguera, JM
    Colmenero, JD
    CLINICAL INFECTIOUS DISEASES, 1996, 23 (02) : 410 - 410
  • [40] Value and limitations of the von Reyn, Duke, and Modified Duke Criteria for the diagnosis of infective endocarditis in children
    Tissières, P
    Gervaix, A
    Beghetti, M
    Jaeggi, ET
    PEDIATRICS, 2003, 112 (06) : E467 - E471